Phibro Animal Health
PAHC· Manufacturing· Fiscal year ends in June
CEO pay in FY2025Stock +52.3% in FY2025
Jack C. Bendheim is the CEO of Phibro Animal Health and was paid $5.3M in FY2025 (Jun), up 11%.
Pay$100 in the stock at the end of FY21 → $96
Executives6
See all- 1Jack C. BendheimChairman of the Board, President, and Chief Executive OfficerFY2025
- 2Larry L. MillerChief Operating OfficerFY2025
- 3Glenn DavidChief Financial OfficerFY2025
- 4Daniel M. BendheimDirector and Executive Vice President, Corporate StrategyFY2025
- 5Judith WeinsteinSenior Vice President, General Counsel and Corporate SecretaryFY2025
- 6Jonathan BendheimDirectorNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allPhibro Animal Health paid its 5 named executives $11.2M in total in FY2025 (Jun). CEO Jack C. Bendheim was paid $5.3M of that.
| Name | |||
|---|---|---|---|
| Jack C. BendheimChairman of the Board, President, and Chief Executive Officer | |||
| Larry L. MillerChief Operating Officer | |||
| Glenn DavidChief Financial Officer | Not disclosed | ||
| Daniel M. BendheimDirector and Executive Vice President, Corporate Strategy | |||
| Judith WeinsteinSenior Vice President, General Counsel and Corporate Secretary | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Phibro Animal Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Carol A. WrennDirector · 14 yr on the boardIndependentAudit, Compensation—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Sep 19, 2025 | FY2025 |
| Annual report | 10-K | Aug 27, 2025 | FY2025 |
| Proxy statement | DEF 14A | Sep 20, 2024 | FY2024 |
| Annual report | 10-K | Aug 28, 2024 | FY2024 |
| Proxy statement | DEF 14A | Sep 15, 2023 | FY2023 |
| Annual report | 10-K | Aug 30, 2023 | FY2023 |